Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: APOLLO Trial: Magnitude And Duration Of Effects Of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial April 3, 2022 Disclosures: TBA
Dr. Lorenz Räber and Dr. Yazan Daaboul Discuss: PACMAN AMI: Effects Of Alirocumab On Coronary Atherosclerosis Assessed By Serial Multimodality Intracoronary Imaging In Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial April 3, 2022 Disclosures: TBA
Dr. Brian Bergmark and Dr. Yazan Daaboul Discuss: TRANSLATE-TIMI 70: Effect Of Vupanorsen On Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol April 3, 2022 Disclosures: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: ACC 2022 Wrap-Up – April 2, 2022 April 2, 2022 Disclosures: TBA
Dr. Tijn Jansen, Dr. Suzette Elias-Smale and Dr. C. Michael Gibson Discuss: Results Of The EDIT-CMD Randomized Clinical Trial: Efficacy Of Diltiazem To Improve Coronary Vasomotor Dysfunction In Angina And Nonobstructive Coronary Arteries April 2, 2022 Disclosures: TBA
Dr. Frederik Zimmermann and Dr. Yaz Daaboul Discuss: The FAME 3 Trial: Quality Of Life After Fractional Flow Reserve-guided Stenting Compared With Coronary Bypass Surgery April 2, 2022 Disclosures: TBA
Dr. Shamir Mehta and Dr. C. Michael Gibson Discuss: COMPLETE: Effects Of Complete Revascularization On Angina-related Quality Of Life In Patients With St-segment Elevation Myocardial Infarction April 2, 2022 Disclosures: TBA
Dr. PJ Devereaux and Dr. Serge Korjian Discuss: The Poise-3 Trial: Efficacy And Safety Of Tranexamic Acid In Patients Undergoing Noncardiac Surgery April 2, 2022 Disclosures: TBA
Dr. Justin Ezekowitz and Dr. C. Michael Gibson Discuss: SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure April 2, 2022 Disclosures: TBA
Dr. Milind Desai and Dr. C. Michael Gibson Discuss: VALOR-HCM: Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy April 2, 2022 Disclosures: TBA
